Theratechnologies inc.
TSX : TH

Theratechnologies inc.

May 05, 2008 12:06 ET

Theratechnologies to Present at BioFinance 2008 Conference

MONTREAL, CANADA--(Marketwire - May 5, 2008) - Theratechnologies (TSX:TH) announced today that Yves Rosconi, President and Chief Executive Officer, will present an overview of the Company at the BioFinance 2008 Conference, which will take place this week in Toronto. Mr. Rosconi will be speaking at 11:00 a.m., on Wednesday, May 7.

BioFinance is the Canadian Life Science industry's leading investor conference that brings together key industry players to consider investment opportunities and issues affecting companies in biotechnology.

About Theratechnologies

Theratechnologies (TSX:TH) is a Canadian biopharmaceutical company that discovers innovative drug candidates in order to develop them and bring them to market. The Company targets unmet medical needs in financially attractive specialty markets. Its most advanced program is tesamorelin, now in a confirmatory Phase 3 clinical trial for a serious metabolic disorder known as HIV-associated lipodystrophy. The Company also has other projects at earlier stages of development.

Contact Information